Diasorin | DIA - Sales Revenues

Stock Price
70.60
Daily Change
0.12 0.17%
Monthly
11.96%
Yearly
-24.59%
Q2 Forecast
68.63

Diasorin reported EUR292.51M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Amplifon EUR 579.9M 72.1M Mar/2026
Avanos Medical USD 182.2M 1.3M Mar/2026
Brookdale Senior Living USD 764.86M 10.77M Mar/2026
Cencora USD 78.4B 7.53B Jun/2026
Diasorin EUR 292.51M 2.49M Mar/2026
Encompass Health USD 1.59B 50M Mar/2026
Enovis USD 589M 13.3M Mar/2026
GE HealthCare Technologies USD 5.7B 555M Dec/2025
OPKO Health USD 148.45M 3.22M Dec/2025
Pediatrix Medical Group USD 493.77M 896K Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026